抗体
选项
-
Rovelizumab (anti-CD11a&CD18)
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG4
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 339086-79-2SMILES: [Rovelizumab] -
Efalizumab (anti-ITGAL)关联靶标: ITGAL
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 恒河猴(Rhesus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 214745-43-4 -
-
TIM1/CD365 Rat mAb关联靶标: HAVCR1
- 简短描述: mAb (RMT1-10); Rat anti Mouse TIM1/CD365 Antibody; Flow, in vivo TIM-1 blockade; Unconjugated
- 种属反应性: 小鼠(Mouse)
- 亚型: Rat IgG2a
- 宿主种属: 大鼠(Rat)
- 克隆号: RMT1-10
- 偶联: Unconjugated
首页
400-620-6333


